Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

Launched by PENN STATE UNIVERSITY · Feb 20, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how starting GLP-1 medications, which are often used to help people lose weight, can change the way individuals think about and react to food. Researchers want to see how these medications might affect food choices and eating behaviors over a three-month period. By understanding these changes, they hope to help people maintain a balanced diet while using weight loss medications.

To participate, individuals should be at least 18 years old and have a body mass index (BMI) over 25, indicating they are overweight or obese. They should not currently be taking any other similar medications and should be fluent in English. Participants will be monitored for their food choices and attitudes towards food before starting the medication and again after three months. This study is still in the planning phase, so no one is being recruited just yet. If you or someone you know is interested in learning more, it's a good idea to keep an eye out for updates on the trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults (18+) with overweight or obesity (BMI \>25 kg/m2)
• • Not currently taking an incretin-based medication at baseline
• • Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
• • Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
• • Fluent in English
• Exclusion Criteria:
• • Adults (18+) without overweight or obesity
• • \<18 years of age at time of testing
• • Adults not taking a GLP-1 Medication
• • Adults taking a compound GLP-1
• • Adults on GLP-1 medication for longer than 2 weeks at baseline
• • Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
• • Not fluent in English